Sigma Full Year 2024/25 ASX Release
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The report highlights significant revenue growth and operational achievements, including the successful onboarding of a new supply contract and a new wholesale industry agreement. The company anticipates future reporting will reflect the merged entity's performance, with no dividend declared for this period. CEO Vikesh Ramsunder emphasized the strong underlying performance and the focus on integration post-merger.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Sigma Healthcare
- Sigma Appendix 4E & Full Year Financial Report
- S&P DJI Announces March 2025 Quarterly Rebalance
- Sigma FY25 Trading Update
- Merger with Chemist Warehouse - Scheme Meeting Results
- Merger with Chemist Warehouse - General Meeting Results
Later from Sigma Healthcare
- Trading Update
- Sigma Full Year FY25 Results Presentation
- Sigma Full Year FY25 ASX Release
- AGM Presentation to Shareholders
- AGM Chairman & CEO Address to Shareholders
Follow Sigma Healthcare into a list and get an email when it puts out news.
Follow Sigma Healthcare